Thursday, August 20, 2015

Lynparza Improves Overall Survival in High-Risk Gastric Cancer (CME/CE)

(MedPage Today) -- But no progression-free survival benefit seen in phase II study
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)